Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus

Vesicular stomatitis virus (VSV) has proven to be an effective vaccine vector for immunization against viral infection, but its potential to induce an immune response to a self-tumor antigen has not been investigated. We constructed a recombinant VSV expressing human dopachrome tautomerase (hDCT) an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bridle, Byram W, Boudreau, Jeanette E, Lichty, Brian D, Brunellière, Jérôme, Stephenson, Kyle, Koshy, Sandeep, Bramson, Jonathan L, Wan, Yonghong
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2009
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2835010/
https://ncbi.nlm.nih.gov/pubmed/19603003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.154
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires